Immune Pharmaceuticals and Hadasit File a Joint Patent...
SWI Editorial Staff2016-06-28T12:16:13-07:00NEW YORK, June 7, 2016 /PRNewswire/ — Immune Pharmaceuticals Inc. (“Immune”), a biopharmaceutical company focused on the development of antibody-based therapeutics for the treatment of inflammatory diseases and cancer, and ...